Delivery Order SPE2DR25D6028-SPE2DR26FAQVG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $10,137.85 to supply Synvisc-One Syringe 6ML, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that serves...
- The Defense Logistics Agency awarded a $13,303.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One syringes (6mL) on September 15, 2025, with an ultimate completion date of September 16, 2025. The award, which carries no set-aside designation, represents a competitive procurement fulfilled by the pharmaceutical distributor from its Conshohocken, Pennsylvania corporate office. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,939.45 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,479.42 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a joint care injection medication. This firm fixed-price contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $30,813.16 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a pharmaceutical product for joint pain management. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,398.41 on July 29, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,069.71 to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a pharmaceutical product used in joint pain management. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by April 25, 2025. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle...
- The Defense Logistics Agency Medical Supply Chain awarded a $58,094.55 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Synvisc-One syringes (6ML, 1 unit). The contract is non-competitive, firm fixed-price delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $13.8K to AmerisourceBergen Drug Corp for Synvisc-One syringes (6mL) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This is a firm fixed price delivery order with a ceiling value of $6,009.24 and an ultimate completion date of July 2, 2025. The contract represents a non-competitive award utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FAQVGDelivery Order
The Defense Logistics Agency awarded a $30,759.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Synvisc-One syringes (6 milliliters, 1 pack) with an ultimate completion date of November 19, 2025. This is a non-set-aside, competitively awarded contract supporting the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA's procurement channels. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical and medical supply support for military healthcare programs worldwide. The contract vehicle covers a broad range of medical commodities including specialty medications, branded and generic drugs, vaccines, and related medical supplies across multiple therapeutic categories, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.8k | 10/22/25 |